Skip to content
healthcare.dev

Furosemide

NDC 63561-0166, FUROSEMIDE, tablet, from Granulation Technology, Inc..

Product NDC
63561-0166
Status
Listed
Labeler
Granulation Technology, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA018569
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63561-0166 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FUROSEMIDE80 mg/1

Pharmacologic classes

Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]

Package NDCNDC-11Package
63561-0166-163561016601100 TABLET in 1 BOTTLE (63561-0166-1)
63561-0166-563561016605500 TABLET in 1 BOTTLE (63561-0166-5)
63561-0166-96356101660990 TABLET in 1 BOTTLE (63561-0166-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/462e8917-cbe0-f4f9-e063-6394a90ab4ff
  • NADAC price for package 63561016605

    GET /v1/drugs/nadac/63561016605

Use it

Look up 63561-0166 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63561-0166 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63561-0166. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.